Table 3.

Indications for prophylactic, empiric and therapeutic use of antifungals in 309 prescriptions^*.

	Prophylaxis N=53	Empiric⁎⁎ N=59	Targeted treatment N=197	Total N=309
Oral candidiasis	2	-	103	105
Candidemia	17	24	7	48
Cryptococcosis	1	1	24	26
Esophageal candidiasis	-	4	22	26
Acute myeloid leukemia	20	-	-	20
Cutaneous candidiasis	-	1	13	14
Vaginal candidiasis	-	2	11	13
Febrile neutropenia	-	11	-	11
Hematopoietic cell transplantation	7	-	-	7
Histoplasmosis	-	5	1	6
Aspergillosis	-	-	5	5
Pneumonia caused by mold	-	4	-	4
Abdominal candidiasis	1	2	-	3
Candiduria	-	1	2	3
Acute lymphoid leukemia	3	-	-	3
Other	2	4	9	15

^⁎24 prescriptions excluded (no apparent reason)

^⁎⁎Cases were classified as empiric when antifungal was started upon a suspicion of the disease (e.g., candidemia), but the diagnosis was not confirmed